TEXAS NODE

TEXAS NODE

Madhukar H. Trivedi, MD [email]
Principal Investigator
University of Texas Southwestern Medical Center
5323 Harry Hines Blvd.
Dallas, TX 75390-9119

Find Node Publications
Node Twitter feed

Node web site
NIDA web site

The Texas Node joined the Clinical Trials Network in September 2005. UT Southwestern faculty collaborate with CTPs representing over 11,000 annual inpatient and outpatient admissions for a primary substance use disorder, with large populations of Hispanic/Latino, African-American, adolescent, and female patients. The CTPs and associated sites also offer specialized treatment and outreach programs for HIV+ patients.


TEXAS NODE PROTOCOL INVOLVEMENT
CTN-0028 Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents (with Substance Use Disorder)
CTN-0030

Prescription Opioid Addiction Treatment Study (POATS)

CTN-0030-A-1 Collection of Economic Data for the Prescription Opioid Addiction Treatment Study
CTN-0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
CTN-0031-A-1 An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association with Treatment Outcomes in Methamphetamine and Cocaine Abusers
CTN-0031-A-2 The Role of Alcohol Consumption in Classifications of Alcohol Use Disorders: A Clinical Study
CTN-0031-A-3 Organizational Characteristics that Influence the Adoption of Evidence-Based Practices
CTN-0036-Ot Epidemiology and Ethnographic Survey of "Cheese" Heroin Use among Hispanics in Dallas County
CTN-0037 Stimulant Reduction Intervention Using Dosed Exercise (STRIDE)
CTN-0037-A-1 Site Influences on Treatment Effects - Exercise as a Treatment for Substance Use Disorders
CTN-0044 Web-Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders
CTN-0046 Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant Dependence
CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB)
CTN-0048-A-1 Pharmacogenetics of Buprenorphine/Naltrexone for Cocaine Dependence in CURB Study
CTN-0049 Project HOPE: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
CTN-0049-A-2 Utilization of the Electronic Medical Record to Assess and Predict 3-Day Readmission Risk Among HIV-Infected Inpatients Enrolled in CTN-0049
CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT)
CTN-0052 A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC)
CTN-0054 Combination Pharmacotherapy for Methamphetamine Dependence: Extended Release Depot Naltrexone + Bupropion vs. Matched Placebos
CTN-0064 Linkage to Hepatitis C Virus (HCV) Care among HIV/HCV Co-infected Substance Users
CTN-0068 Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
CTN-0090 Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution (NIH HEAL Initiative)
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 9/2019 -- http://ctndisseminationlibrary.org/nodes/txnode.htm
info@ctndisseminationlibrary.org